Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Envoy Medical, Inc. - Class A Common Stock (NQ:COCH)

0.8057 -0.0043 (-0.53%)
Streaming Delayed Price Updated: 3:30 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Envoy Medical, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
Life Sciences Investor Forum Agenda Announced for June 11th-12th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up
White Bear Lake, Minnesota--(Newsfile Corp. - June 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing... 
Via Newsfile
Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial
White Bear Lake, Minnesota--(Newsfile Corp. - May 13, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing... 
Via Newsfile
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Envoy Medical Reports on First Quarter 2025 Results
White Bear Lake, Minnesota--(Newsfile Corp. - May 1, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing... 
Via Newsfile
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Company Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in its Pivotal Clinical Study for Breakthrough Device,... 
Via Newsfile
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
White Bear Lake, Minnesota--(Newsfile Corp. - March 17, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing... 
Via Newsfile
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device
White Bear Lake, Minnesota--(Newsfile Corp. - March 12, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing... 
Via Newsfile
Envoy Medical to Participate in the 37th Annual ROTH Conference
White Bear Lake, Minnesota--(Newsfile Corp. - March 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing... 
Via Newsfile
First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant
White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health... 
Via Newsfile
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio
White Bear Lake, Minnesota--(Newsfile Corp. - February 14, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health... 
Via Newsfile
Topics Intellectual Property
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study
White Bear Lake, Minnesota--(Newsfile Corp. - December 19, 2024) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health... 
Via Newsfile
Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss
From Envoy Medical, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System
From Envoy Medical, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device
From Envoy Medical, Inc
Via GlobeNewswire
Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical to Present at the LD Micro Main Event XVII
From Envoy Medical, Inc
Via GlobeNewswire
American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem® Device
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market
From Envoy Medical, Inc
Via GlobeNewswire
Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical Awarded Patent for Recharge System used with Implantable Battery
From Envoy Medical, Inc
Via GlobeNewswire
Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying
 
Via Benzinga
Envoy Medical Secures Lending Facility of $10M
From Envoy Medical, Inc
Via GlobeNewswire
COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q2 2024
COCH stock results show that Envoy Medical missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage
From Envoy Medical, Inc
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.